Analytical procedure for the determination of tulathromycin in swine plasma

• Autorzy: Gajda A. , Posyniak A. , Bladek T.
• Języki publikacji: EN

Abstrakty

EN

For the measurement of tulathromycin distribution in swine plasma an accurate and reliable analytical method was developed. The extraction was performed with oxalic acid buffer (pH=4.0). Plasma samples were cleaned up by solid phase extraction procedure using polymeric cartriges. Chromatographic separation was achieved on a C 18 analytical column using mobile phase consisting of acetonitrile, 0.1% formic acid in gradient mode. Detection was carried out by liquid chromatography tandem mass spectrometry. Azithromycin was used as internal standard. The method has been successfully validated. The recovery from spiked samples ranged from 94% to 110%. The limit of detection was 2 ng/mL and the limit of quantification was 5 ng/mL. The method was developed to investigate the pharmacokinetics of tulathromycin in swine plasma. Applicability of the method was tested with plasma from swine administered with a single dose of tulathromycin.

• Wydawca: -
• Czasopismo: Bulletin of the Veterinary Institute in Puławy
• Rocznik: 2013
• Tom: 57
• Numer: 2
• Opis fizyczny: p.191-195,fig.,ref.

Twórcy

autor

Gajda A.

• Department of Pharmacology and Toxicology, National Veterinary Research Institute, 24-100 Pulawy, Poland

autor

Posyniak A.

• Department of Pharmacology and Toxicology, National Veterinary Research Institute, 24-100 Pulawy, Poland

autor

Bladek T.

• Department of Pharmacology and Toxicology, National Veterinary Research Institute, 24-100 Pulawy, Poland

Bibliografia

• 1. Anon. U.S. Department of Health and Human Services, Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine: Guidance for Industry, Bioanalytical Method Validation, 2001.
• 2. Anon. European Medicines Agency (EMFA): Guideline on bioanalytical method validation, 2011.
• 3. Benchaoui H.A., Nowakowski M., Sherington J., Rowan T.G., Sunderland S.J.: Pharmacokinetics and lung tissue concentrations of tulathromycin in swine. J Vet Pharmacol Therap 2004, 27, 203-210.
• 4. Böhm D.A., Stachel C.S., Gowik P.: Multi-method for the determination of antibiotics of different substance groups in milk and validation in accordance with Commission Decision 2002/657/EC. J Chromatogr A 2009, 1216, 8217-8223.
• 5. Boner P.L., Gottschall D.W., Kim-Kang H.: Determination and confirmation of tulathromycin residues in bovine liver and porcine kidney via their common hydrolytic fragment using high-performance liquid chromatography/tandem mass spectrometry. J AOAC Int 2011, 94, 436-445.
• 6. Charles L., Segreti J.: Choosing the right macrolide antibiotic. A guide to selection. Drugs 1997, 53, 349- 357.
• 7. Darrington R.T., Zhang L., Ji Q., Rafka R.J., Morton B.J.: Equilibrium, kinetics, and mechanism of acyl migration in tulathromycin, a novel triamilide antibiotic. AAPS Pharm Sci 2003, 5, 1187-1189.
• 8. Galer D., Hessong S., Beato B., Risk J., Inskeep P., Weerasinghe C., Schneider R., Langer C., LaPerle J., Renouf D., Bessire A., Español E., Rafka R., Ragan C., Boettner W., Murphy T., Keller D., Benchaoui H., Nowakowski M.: An analytical method for the analysis of tulathromycin, an equilibrating triamilide, in bovine and porcine plasma and lung. J Agrie Food Chem 2004, 52, 2179-2191.
• 9. Martos P.A., Lehotay S.J., Shurmer B.: Ultratrace analysis of nine macrolides, including tulathromycin A (Draxxin), in edible animal tissues with minicolumn liquid chromatography tandem mass spectrometry. J Agrie Food Chem 2008, 56, 8844-8850.
• 10. Nowakowski M.A., Inskeep P.B., Risk J.E., Skogerboe T.L., Benchaoui H.A., Meinert T.R., Sherington J., Sunderland S.J.: Pharmacokinetics and lung tissue concentrations of tulathromycin, a new triamilide antibiotic in cattle. Vet Therap 2004, 5, 60-74.
• 11. Nutsch R.G., Hart F.J., Rooney K.A., Weigel D.J., Kilgore W.R., Skogerboe T.L.: Efficacy of tulathromycin injectable solution for the treatment of naturally occurring swine respiratory disease. Vet Therapeutics: Res Appl Vet Med 2005, 6, 214-224.
• 12. Scheuch E., Spieker J., Venner M., Siegmund W.: Quantitative determination of the macrolide antibiotic tulathromycin in plasma and broncho-alveolar cells of foals using tandem mass spectrometry. J Chromatogr B 2007, 850, 464-470.
• 13. Wang X., Tao Y.F., Huang L.L., Chen D.M., Yin S.Z., Ihsan A., Zhou W., Su S.J., Liu Z.L., Pan Y.H., Yuan Z.H.: Pharmacokinetics of tulathromycin and its metabolite in swine administered with an intravenous bolus injection and a single gavage. J Vet Pharmacol Therap 2012, 35, 282-289.
• 14. Young G., Smith G.W., Leavens T.L., Wetzlich S.E., Baynes R.E., Mason S.E., Riviere J.E., Tell L.A.: Pharmacokinetics of tulathromycin following subcutaneous administration in meat goats. Res Vet Sci 2011, 90, 477-479.
• 15. Zhanel G.G., Dueck M., Hoban D.J., Vercaigne L.M., Embil J.M., Gin A.S., Karłowski J.A.: Review of macrolides and ketolides - focus on respiratory tract infections. Drugs 2001, 61, 443-498.